Ignite Creation Date:
2024-05-05 @ 12:01 PM
Last Modification Date:
2024-10-26 @ 9:18 AM
Study NCT ID:
NCT00212069
Status:
COMPLETED
Last Update Posted:
2013-12-11
First Post:
2005-09-13
Brief Title:
Serum Proteomics to Predict Gemcitabine Sensitivity in Breast Cancer
Sponsor:
National University Hospital Singapore
Organization:
National University Hospital Singapore
Organization Data
Organization:
National University Hospital Singapore
Class:
OTHER
Study ID:
BR011203
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
National University Hospital Singapore
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None